Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DRTS | US
0.11
1.38%
Healthcare
Biotechnology
30/06/2024
24/04/2026
8.09
8.01
8.35
7.65
Alpha Tau Medical Ltd. a clinical-stage oncology therapeutics company engages in research development and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin oral pancreatic prostate and breast cancers; and preclinical studies for brain hepatic cell carcinoma glioblastoma multiforme lung cancer and others. The company was incorporated in 2015 and is headquartered in Jerusalem Israel.
View LessPositive Momentum
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
31.6%1 month
43.7%3 months
62.9%6 months
75.5%-
-
2.13
0.17
0.13
-4.77
-
-
-35.22M
565.69M
565.69M
-
-
-
-
-33.17
1.60
0.08
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.30
Range1M
2.09
Range3M
2.50
Rel. volume
1.12
Price X volume
2.31M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ANNX | ANNX | Biotechnology | 5.88 | 621.25M | -2.97% | n/a | 8.36% |
| Lexicon Pharmaceuticals Inc | LXRX | Biotechnology | 1.68 | 607.31M | 0.00% | n/a | 44.04% |
| Eton Pharmaceuticals Inc | ETON | Biotechnology | 23.02 | 594.75M | 0.22% | n/a | 36.23% |
| Prothena Corporation plc | PRTA | Biotechnology | 10.75 | 578.14M | 0.19% | n/a | 2.08% |
| Adlai Nortye Ltd. | ANL | Biotechnology | 14.8 | 546.12M | -0.74% | n/a | 72.87% |
| Kezar Life Sciences Inc | KZR | Biotechnology | 7.33 | 534.81M | 0.83% | n/a | 11.69% |
| Rigel Pharmaceuticals Inc | RIGL | Biotechnology | 30.29 | 532.95M | -1.40% | n/a | -201.68% |
| ZVRA | ZVRA | Biotechnology | 10.08 | 530.39M | -0.30% | n/a | 183.10% |
| Fulcrum Therapeutics Inc | FULC | Biotechnology | 7.84 | 489.22M | -2.97% | n/a | 3.53% |
| 4D Molecular Therapeutics Inc | FDMT | Biotechnology | 9.4 | 488.51M | -2.19% | n/a | 2.32% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Ennis Inc | EBF | Building Products & Equipment | 20.33 | 528.66M | -1.26% | 13.28 | 2.28% |
| Malibu Boats Inc | MBUU | Recreational Vehicles | 26.1 | 521.76M | -0.91% | n/a | 1.50% |
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 23.53 | 390.77M | -0.88% | 34.27 | 26.82% |
| Camping World Holdings Inc | CWH | Recreational Vehicles | 7.48 | 337.57M | 8.41% | n/a | 3644.76% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.31 | 317.09M | 1.85% | n/a | 174.23% |
| Marine Products Corporation | MPX | Recreational Vehicles | 7.99 | 277.39M | -0.99% | 13.23 | 0.00% |
| Urban One Inc | UONEK | Broadcasting - Radio | 4.9543 | 262.62M | -0.42% | n/a | 268.43% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 18.17 | 202.74M | 2.83% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 11.3 | 181.44M | 2.73% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 36.11 | 103.70M | 0.00% | 5.16 | 19.82% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -4.77 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.13 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 62.91 | 72.80 | Par |
| Debt to Equity | 0.17 | -1.23 | Expensive |
| Debt to Assets | 0.13 | 0.25 | Cheaper |
| Market Cap | 565.69M | 3.66B | Emerging |